Response to: Biosimilars for vasculitis: promise requires validation by quality studies
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Rheumatology"
DOI: 10.1007/s10067-020-05381-0
Abstract: We thank Misra et al. for their interest in our paper on the role of similar biological rituximab in remission induction and maintenance in granulomatosis with polyangiitis [1, 2]. They reviewed the available published literature… read more here.
Keywords: rituximab; aav; quality; use ... See more keywords